Global Recombinant Proteins Manufacturing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Recombinant Proteins Manufacturing Services Market is presumed to reach the market size of nearly USD 7.6 Billion by 2032 from USD 2.76 Billion in 2023 with a CAGR of 11.89% under the study period 2024-2032.

Recombinant protein manufacturing services refer to the processes and facilities offered by biotechnology and contract manufacturing organizations (CMOs) to produce recombinant proteins for various purposes. Recombinant proteins are produced by genetically engineering organisms, typically bacteria, yeast, mammalian cells, or even plants, to express specific proteins of interest. These proteins are used in various fields, including pharmaceuticals, biotechnology, research, diagnostics, and industrial applications.

MARKET DYNAMICS

The recombinant proteins manufacturing services market is experiencing growth due to several key factors. The expansion of the biopharmaceutical industry, driven by the demand for biologic drugs like monoclonal antibodies and vaccines, is a primary driver. Biologic drugs are increasingly used in treating various diseases, necessitating the production of recombinant proteins, which these services provide. Research and development activities in life sciences and biotechnology, advancements in genetic engineering, and the outsourcing trend in contract manufacturing further boost demand. The rising prevalence of chronic diseases, the imperative for pandemic preparedness highlighted by COVID-19, and ongoing technological advancements in protein expression and purification techniques contribute to the market's growth. Regulatory approvals, especially in the biopharmaceutical sector, ensure the demand for reliable and compliant manufacturing services. Emerging markets and the customization options service providers offer also play a role.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Recombinant Proteins Manufacturing Services. The growth and trends of Recombinant Proteins Manufacturing Services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Recombinant Proteins Manufacturing Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services Scope

Product (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Others)
Production Services

By Application Scope

Drug Discovery & Development
Therapeutics (Biologics, Vaccines, Cell & Gene Therapies, Others)
Research
Others

By End-user Scope

Pharma & Biotechnology Companies
Academic & Research Institutes
Diagnostic Laboratories
Others

By Host Cell Scope

Mammalian Systems
Insect Cells
Yeast & Fungi
Bacterial Cells
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Recombinant Proteins Manufacturing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Recombinant Proteins Manufacturing Services market include Abcam Plc, Sino Biological Inc., R&D Systems Inc., GenScript, Bio-Rad Laboratories Inc., Merck KGaA, Thermo Fisher Scientific, Proteintech Group Inc., Enzo Life Sciences Inc., Abnova Corp., RayBiotech Life Inc., Stemcell Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112237

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. RECOMBINANT PROTEINS MANUFACTURING SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Services Scope
- 3.7.2 Market Attractiveness Analysis By Application Scope
- 3.7.3 Market Attractiveness Analysis By End-user Scope
- 3.7.4 Market Attractiveness Analysis By Host Cell Scope
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY PRODUCT & SERVICES SCOPE

5.1. Overview By Product & Services Scope
5.2. Historical and Forecast Data
5.3. Analysis By Product & Services Scope
5.4. Product (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILs), Others), Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes (Kinases, Metabolic Enzymes, Others), Recombinant Regulatory Protein, Hormones, Others) Historic and Forecast Sales By Regions
5.5. Production Services Historic and Forecast Sales By Regions

6. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY APPLICATION SCOPE

6.1. Overview By Application Scope
6.2. Historical and Forecast Data
6.3. Analysis By Application Scope
6.4. Drug Discovery & Development Historic and Forecast Sales By Regions
6.5. Therapeutics (Biologics, Vaccines, Cell & Gene Therapies, Others) Historic and Forecast Sales By Regions
6.6. Research Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY END-USER SCOPE

7.1. Overview By End-user Scope
7.2. Historical and Forecast Data
7.3. Analysis By End-user Scope
7.4. Pharma & Biotechnology Companies Historic and Forecast Sales By Regions
7.5. Academic & Research Institutes Historic and Forecast Sales By Regions
7.6. Diagnostic Laboratories Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL RECOMBINANT PROTEIN MARKET ANALYSIS BY HOST CELL SCOPE

8.1. Overview By Host Cell Scope
8.2. Historical and Forecast Data
8.3. Analysis By Host Cell Scope
8.4. Mammalian Systems Historic and Forecast Sales By Regions
8.5. Insect Cells Historic and Forecast Sales By Regions
8.6. Yeast & Fungi Historic and Forecast Sales By Regions
8.7. Bacterial Cells Historic and Forecast Sales By Regions
8.8. Others Historic and Forecast Sales By Regions

9. GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE RECOMBINANT PROTEINS MANUFACTURING SERVICES COMPANIES

10.1. Recombinant Protein Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF RECOMBINANT PROTEINS MANUFACTURING SERVICES INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Abcam Plc
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Sino Biological Inc.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. R&D Systems Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. GenScript
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Bio-Rad Laboratories Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Merck KGaA
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Thermo Fisher Scientific
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Proteintech Group Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Enzo Life Sciences Inc.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Abnova Corp.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. RayBiotech Life Inc.
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Stemcell Technologies Inc
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies